1Day CP. Non - alcoholic steatohepatitis ( NASH ) : where are we now and where are we going[J]. Gut,2002,50:585 -588.
2Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury[J]. J Biol Chem, 2000, 275(4) : 2247 - 2250.
3Wang SC,Ohata M,Schrum L,et al. Expression of interleukin - 10 by in vitro and in vivo activated hepatic stellate cells[ J ]. J Biol Chem, 1998,273:302 -308.
4Thompson KC, Maltby J, Fallowfield J, et al. Interleukin - 10 expression and function in experimental routine liver inflammation [ J ]. Hepatology, 1998,28 : 1597 - 1606.
5Nelson DR,Lauwers GY, Lau JY, et al. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C : a pilot trial of interferon nonresponders [ J ]. Gastroenterology,2000,118:655 - 660.
6Tilg H, Jalan R, Kaser A, et al. Anti - tumour necrosis factor - alpha monoclonal antibody therapy in severe alcoholic hepatitis [ J ]. J Hepatol,2003,38:419 - 425.
7Border WA, George J, Roulot D, et al. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type Ⅱ receptor: a potential new therapy for hepatic fibrosis [ J]. Proc Natl Aead Sci USA, 1999,96 : 12719 - 12724.
8Bataller R, Brenner D. Hepatic stellate cells as a target for the treatment of liver fibrosis [ J ]. Semin Liver Dis,2001,21 ( 3 ) :437 - 451.
9Benyon RC, Arthur MJP. Extracellular matrix degradation and the role of hepatic stellate cells[ J]. Semin Liver Dis,2001,21:373 -384.
10Kweon YO, Goodman ZD, Dienstag JL, et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B[ J]. J Hepatol, 2001,35 : 749 - 755.
